The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Imidazole‐Based Synthetic Lipidoids for In Vivo mRNA Delivery into Primary T Lymphocytes
Abstract
Engineering T lymphocytes is an emerging approach in a variety of biomedical applications. However, delivering large biologics to primary T lymphocytes directly in vivo is technically challenging due to the low transfection efficacy. Herein, we investigated a library of synthetic lipid‐like molecules (lipidoids) for their capability of delivering mRNA into primary T lymphocytes both ex vivo and in vivo. We initially screened a library with a large structural variety of lipidoids ex vivo and identified imidazole‐containing lipidoids that are particularly potent in T lymphocytes transfection. We further optimized lipidoid structures by constructing and screening a detailed lipidoid library containing imidazole or imidazole analogues to perform a structure–activity correlation analysis. Using the lead lipidoid as a delivery vehicle for Cre mRNA in vivo through intravenous injection, we achieved 8.2 % gene recombination in mouse T lymphocytes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A robust and high-throughput Cre reporting and characterization system for the whole mouse brain
Madisen, L., Zwingman, T. A., Sunkin, S. M., Oh, S. W., Zariwala, H. A., Gu, H., Ng, L. L., Palmiter, R. D., Hawrylycz, M. J., Jones, A. R., et al. (2010) · Nature Neuroscience · doi:10.1038/nn.2467 · Cited by 6,907
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
Kranz, L. M., Diken, M., Haas, H., Kreiter, S., Loquai, C., Reuter, K. C., Meng, M., Fritz, D., Vascotto, F., Hefesha, H., et al. (2016) · Nature · doi:10.1038/nature18300 · Cited by 1,819
Global Manufacturing of CAR T Cell Therapy
Levine, B. L., Miskin, J., Wonnacott, K., & Keir, C. (2017) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2016.12.006 · Cited by 765
Miao, L., Li, L., Huang, Y., Delcassian, D., Chahal, J., Han, J., Shi, Y., Sadtler, K., Gao, W., Lin, J., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0247-3 · Cited by 723
Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy
Oberli, M. A., Reichmuth, A. M., Dorkin, J. R., Mitchell, M. J., Fenton, O. S., Jaklenec, A., Anderson, D. G., Langer, R., & Blankschtein, D. (2017) · Nano Letters · doi:10.1021/acs.nanolett.6b03329 · Cited by 719
High-Efficiency Transfection of Primary Human and Mouse T Lymphocytes Using RNA Electroporation
Zhao, Y., Zheng, Z., Cohen, C. J., Gattinoni, L., Palmer, D. C., Restifo, N. P., Rosenberg, S. A., & Morgan, R. A. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.07.688 · Cited by 283
Kwon, H., Kim, M., Seo, Y., Moon, Y. S., Lee, H. J., Lee, K., & Lee, H. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2017.11.034 · Cited by 208
Research works printed but not linked: 34
- 10.1038/nature22395 · DOI · Paper page
- 10.3389/fonc.2018.00315 · DOI · Paper page
- 10.1038/s41573-018-0006-z · DOI · Paper page
- 10.1007/s11899-019-0498-6 · DOI
- 10.3389/fbioe.2019.00131 · DOI
- 10.1158/2326-6066.CIR-17-0189 · DOI · Paper page
- 10.1038/s41586-018-0326-5 · DOI · Paper page
- 10.1089/hum.2011.070 · DOI · Paper page
- 10.1089/hum.2018.145 · DOI
- 10.1016/j.canlet.2019.04.040 · DOI
- 10.1038/s41571-019-0297-y · DOI · Paper page
- 10.1016/j.biomaterials.2019.119401 · DOI
- 10.1038/nnano.2017.57 · DOI · Paper page
- 10.1073/pnas.1805358115 · DOI · Paper page
- 10.1016/j.jconrel.2015.12.032 · DOI · Paper page
- 10.1016/j.jconrel.2018.02.043 · DOI · Paper page
- 10.1021/acs.nanolett.9b04246 · DOI · Paper page
- 10.4155/tde-2016-0006 · DOI · Paper page
- 10.1002/adma.201606944 · DOI · Paper page
- 10.1016/j.jconrel.2009.10.023 · DOI
- 10.1016/j.jconrel.2016.03.001 · DOI
- 10.1039/C8BM00637G · DOI
- 10.1002/anie.200351244 · DOI · Paper page
- 10.1002/ange.200351244 · DOI
- 10.1073/pnas.1520244113 · DOI · Paper page
- 10.1016/j.biomaterials.2018.03.011 · DOI
- 10.1021/bc200572w · DOI
- 10.2217/nnm.14.192 · DOI
- 10.1016/j.nano.2013.01.006 · DOI
- 10.1002/anie.201311245 · DOI · Paper page
- 10.1002/ange.201311245 · DOI
- 10.1111/j.1476-5381.2009.00288.x · DOI · Paper page
- 10.1093/nar/gni085 · DOI · Paper page
- 10.1038/nbt0696-760 · DOI
Cited by
Lipid nanoparticles for mRNA delivery
Hou, X., Zaks, T., Langer, R., & Dong, Y. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00358-0 · Cited by 4,076
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
Chaudhary, N., Weissman, D., & Whitehead, K. A. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00283-5 · Cited by 1,555
The clinical progress of mRNA vaccines and immunotherapies
Barbier, A. J., Jiang, A. Y., Zhang, P., Wooster, R., & Anderson, D. G. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01294-2 · Cited by 823
mRNA-based therapeutics: powerful and versatile tools to combat diseases
Qin, S., Tang, X., Chen, Y., Chen, K., Fan, N., Xiao, W., Zheng, Q., Li, G., Teng, Y., Wu, M., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01007-w · Cited by 771
Dilliard, S. A., & Siegwart, D. J. (2023) · Nature Reviews Materials · doi:10.1038/s41578-022-00529-7 · Cited by 671
Metadata
- Authors
- Zhao, X., Chen, J., Qiu, M., Li, Y., Glass, Z., & Xu, Q.
- Venue
- Angewandte Chemie International Edition
- Publisher
- Wiley
- Published
- 2020-08-28
- Volume
- 59
- Issue
- 45
- Pages
- 20083-20089
- ISSN
- 1433-7851 (ISSN-L)
- 1521-3773
- OpenAlex
- W3042724979
- Cited by
- 179
- References
- 7
- FWCI
- 4.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Funders
- National Institutes of Health (R01 EB027170-01, UG3 TR002636-01, S10 OD021624)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Imidazole‐Based Synthetic Lipidoids for In Vivo mRNA Delivery into Primary T Lymphocytes. https://app.cochat.ai/papers/10.1002/anie.202008082
- The paper
- Zhao, X., Chen, J., Qiu, M., Li, Y., Glass, Z., & Xu, Q. (2020). Imidazole‐Based Synthetic Lipidoids for In Vivo mRNA Delivery into Primary T Lymphocytes. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202008082
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.